Olink Investor Relations Material
Latest events
Q2 2023
Olink
Q1 2024
13 May, 2024
Q4 2023
25 Mar, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Olink Holding AB
Access all reports
Olink Holding AB develops and markets proteomics solutions for academic and pharmaceutical research. The company’s technology platform enables high-throughput protein biomarker discovery and validation. It serves customers in biomarker research, drug development, and diagnostics. The company is headquartered in Uppsala, Sweden, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
OLK
Country
🇺🇸 United States